We developed a biosensor to evaluate drugs by detecting changes in living cells.
Sign up to see how you are connected to InVitroMetrix
There was a problem loading your content.
Our system is a digital cell biosensor technology that uses cell diversity to model in vitro the response to drugs in a quantitative manner. This occurs through the combination of (1) access to a diverse human cell source, (2) innovative instrumentation to probe the cells, and (3) drug library for matching mechanistic actions of cells of novel drugs to know drugs, all in an automated method.
Our… · More current market is that of Biosensors research devices ($11.5B/yr) for the drug discovery and development. Our specific target is biologics and Immunotherapy drugs. Pharmaceutical companies are increasing these in their pipeline, but lack Organ-Simulation and Cell-specific Phenotypic Testing or Immunogenicity Assay Assessment.
Our market is to serve the pharmaceutical and medical industry in providing devices for their research and diagnostic needs. Our cell based method allows for disease and genetic diversity by using human cells from patients to perform in vitro research.